|People of API|
New at API
We are excited to introduce you to our new Lab Technician, Bruna Dutra.
Bruna holds a Bachelor’s Degree in Pharmacy from in Brazil, and a Master’s in Science in Translational Medicine from the University of Alberta.
“I am very passionate about life sciences research and drug development, and I applied to work with API as soon as I completed my MSc! API offers endless learning opportunities for anyone who is starting their career in the life sciences and I am very excited to learn directly from industry experts.”
New at API
We are thrilled to welcome Archana Koul to the team. She had been working with us as a Postdoctoral Fellow and has transitioned to a new role as a Scientist (S1).
Archana holds a Masters in Plant Biotechnology and a Ph.D. in Molecular Biology. During her Ph.D., she worked on isolating and characterizing anti-cancerous metabolites along with cloning, gene expression and microRNA studies.
“I have always been curious about the drug development process and its related studies. I saw an opportunity to make a difference by focusing on plant based studies to explore treatments and cures for diseases. As a postdoc, the experts at API were able to mentor me and help me grow into a better researcher. In addition to that, API’s platform and its work culture are so inclusive and empowering for women. This gave me the flexibility to maintain work-life balance while working on projects that one can only dream about!”
Archana Koul, Scientist at API
Canadian Symposium for Computational Neurosciences
We are excited to sponsor the first ever Canadian Symposium for Computational Neuroscience, being held October 26-27, 2021.
This national symposium will be held virtually and will connect trainees, researchers, and industry representatives from across the country to share knowledge, research and innovation.
Diversity among directors and executives in the Canadian life sciences industry
Increasingly, corporations and organizations are recognizing the disparities in the industry and are launching initiatives to improve the level of representation of both women and people of colour in senior roles in life sciences companies.
Seven Important Questions About Covid Antivirals Answered
New medicines may stop the virus from replicating so your immune system can fight a few viral soldiers instead of an army.
Revising Our Regulatory Approach To Oral Antivirals For COVID-19
Oral antivirals could serve as an outpatient treatment for symptomatic COVID-19 infection, post-exposure prophylaxis, and as a therapeutic alternative for individuals unable to receive the vaccine due to medical comorbidities.
To view the online version of the newsletter and subscribe, click the below link: